Refine by
Lithotripter Articles & Analysis
14 news found
EMPOWER CAD is the First Prospective, Female-Only Study of Coronary Interventions Study Seeks to Confirm Benefits of Shockwave’s Coronary IVL in Females Who Historically Have Suffered Less Favorable Clinical Outcomes than Male Patients with Traditional Therapies Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely ...
In a release issued under the same headline on August 26, 2022, by Shockwave Medical, Inc. (NASDAQ: SWAV), please note that the fireside chat time for the Wells Fargo Healthcare Conference has been updated. The correct presentation time is 9:10 am Eastern Time. The details for the Morgan Stanley Healthcare Conference remain the same. The corrected release appears below: Shockwave Medical, Inc. ...
Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the company will be participating in two upcoming virtual investor conferences: The 2022 Wells Fargo Healthcare Conference Fireside Chat on Thursday, September 8, 2022, at 9:45 a.m. Eastern Time. The Morgan Stanley ...
Looking forward to @Urovivo2022, the most outstanding urology course in Argentina and live flexible ureteroscopic lithotripsy by Prof. Evangelos Liatsikos with #PUSEN leading & advanced 7.5Fr ureteroscope. #urology #fURS #RIRS #Urovivo ...
Lite-Med’s Extracorporeal Shock Wave Lithotripter (ESWL) LM-9200ELMA (who won the 2018 Taiwan Excellence Award) was exhibited at the MEDICA Taiwan Excellence Exhibit in Germany. ...
SANUWAVE Health, Inc. (OTCQB:SNWV), a leading provider of next-generation advanced wound care medical systems for the repair and regeneration of skin and vascular structures and the research for new applications for shockwave systems in the non-medical field, announced today the patent activity for the full year 2020 and the first quarter of ...
Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, and Genesis MedTech Group announced today that they have successfully obtained approval from China’s National Medical Products Administration (NMPA) to market and sell the Shockwave IVL System with the Shockwave C2 Coronary IVL Catheters ...
Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that long-term data from the Disrupt PAD III trial found that superior vessel preparation with IVL led to excellent long-term outcomes out to two years with preservation of future treatment options compared to percutaneous ...
Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today new data confirming excellent one-year outcomes with coronary IVL in both women and men. The one-year results from the Disrupt CAD clinical program were presented at the 2022 Scientific Sessions of the Society for ...
Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, today announced the global commercial availability of the Shockwave M5+ peripheral IVL catheter after receiving both CE Mark and U.S. Food and Drug Administration (FDA) clearance. The Shockwave M5+ catheter, which has been in limited launch ...
Saluda Medical Pty Limited (“Saluda Medical”), a global medical device company on a mission to revolutionize the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies designed to treat debilitating neurological disorders, today announced the appointment of Doug Godshall as Chairman of its Board of Directors. Mr. Godshall succeeds ...
Lite-Med collaborated with UAA and shared the case study results of LM-9200ELMA and LM-IASO at conference of urological disease treatment using extracoporeal shock wave lithotripsy (ESWL) at Royal Phnom Penh Hospital, Cambodia, January 2019. The case studies were presented by Prof. Allen W. Chiu (Taiwan), Prof. Edward CS Chen and Prof. Hung-Jen ...
Lite-Med’s extracorporeal shock wave lithotripter, which is a Taiwanese medical product, is honored to be included in this issue of Japanese and English Mook, to promote Taiwanese Excellence award-winning products in Japanese and global market. ...
This is a confirmation of Lite-Med’s success in developing extracorporeal shock wave lithotripter (ESWL), transforming the existing Taiwan existing medical device market to use locally manufacutred devices. ...